Fingerprint
Dive into the research topics of 'Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer
- Philip A. Philip
- , Michelle R. Mahoney
- , Kyle D. Holen
- , Donald W. Northfelt
- , Henry C. Pitot
- , Joel Picus
- , Patrick J. Flynn
- , Charles Erlichman
Research output: Contribution to journal › Article › peer-review
62
Scopus
citations